Raymond James Trust N.A. Abbott Laboratories Transaction History

Raymond James Trust N.A.

$4.55 Billion
Q3 2024

A detailed history of Raymond James Trust N.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Raymond James Trust N.A. holds 203,379 shares of ABT stock, worth $23.6 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares

203,379

Previous 209,265 2.81%

Holding current value

$23.6 Million

Previous $21.7 Million 6.64%

% of portfolio

0.51%

Previous 0.52%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $589,012 - $695,313	-5,886 Reduced 2.81%	203,379 $23.2 Million
Q2 2024 Jul 25, 2024	BUY	$100.73 - $112.44 $360,009 - $401,860	3,574 Added 1.74%	209,265 $21.7 Million
Q1 2024 Apr 24, 2024	BUY	$109.52 - $120.96 $175,779 - $194,140	1,605 Added 0.79%	205,691 $23.4 Million
Q4 2023 Jan 10, 2024	SELL	$90.19 - $110.4 $528,603 - $647,054	-5,861 Reduced 2.79%	204,086 $22.5 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $594,769 - $713,624	6,226 Added 3.06%	209,947 $20.3 Million
Q2 2023 Aug 15, 2023	BUY	$100.78 - $112.29 $1.62 Million - $1.8 Million	16,028 Added 8.54%	203,721 $22.2 Million
Q1 2023 May 03, 2023	BUY	$96.86 - $114.01 $593,073 - $698,083	6,123 Added 3.37%	187,693 $19 Million
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $397,065 - $465,819	4,177 Added 2.35%	181,570 $19.9 Million
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $505,764 - $585,580	5,227 Added 3.04%	177,393 $17.2 Million
Q2 2022 Jul 14, 2022	SELL	$102.07 - $123.37 $593,537 - $717,396	-5,815 Reduced 3.27%	172,166 $18.7 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $173,994 - $212,175	1,526 Added 0.86%	177,981 $21.1 Million
Q4 2021 Jan 31, 2022	SELL	$115.53 - $141.46 $1.13 Million - $1.39 Million	-9,800 Reduced 5.26%	176,455 $24.8 Million
Q3 2021 Oct 18, 2021	SELL	$116.66 - $129.06 $354,296 - $391,955	-3,037 Reduced 1.6%	186,255 $22 Million
Q2 2021 Jul 20, 2021	BUY	$105.79 - $124.53 $2.76 Million - $3.25 Million	26,074 Added 15.97%	189,292 $21.9 Million
Q1 2021 May 03, 2021	BUY	$108.84 - $128.23 $605,368 - $713,215	5,562 Added 3.53%	163,218 $19.6 Million
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $237,720 - $259,046	2,264 Added 1.46%	157,656 $17.3 Million
Q3 2020 Oct 14, 2020	SELL	$91.64 - $111.29 $229,924 - $279,226	-2,509 Reduced 1.59%	155,392 $16.9 Million
Q2 2020 Jul 16, 2020	BUY	$76.57 - $98.0 $122,588 - $156,898	1,601 Added 1.02%	157,901 $14.4 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $65,646 - $95,993	1,045 Added 0.67%	156,300 $12.3 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $28,734 - $31,988	-366 Reduced 0.24%	155,255 $13.5 Million
Q3 2019 Oct 24, 2019	BUY	$81.84 - $88.74 $209,428 - $227,085	2,559 Added 1.67%	155,621 $13 Million
Q2 2019 Jul 15, 2019	SELL	$72.88 - $85.0 $352,739 - $411,400	-4,840 Reduced 3.07%	153,062 $12.9 Million
Q1 2019 Apr 15, 2019	SELL	$66.22 - $80.06 $93,436 - $112,964	-1,411 Reduced 0.89%	157,902 $12.6 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $527,495 - $597,576	-8,046 Reduced 4.81%	159,313 $11.5 Million
Q3 2018 Oct 16, 2018	BUY	$60.81 - $73.36 $62,755 - $75,707	1,032 Added 0.62%	167,359 $12.3 Million
Q2 2018 Jul 11, 2018	BUY	$57.57 - $63.54 $66,896 - $73,833	1,162 Added 0.7%	166,327 $10.1 Million
Q1 2018 Apr 05, 2018	SELL	$56.27 - $63.62 $88,906 - $100,519	-1,580 Reduced 0.95%	165,165 $9.9 Million
Q4 2017 Feb 02, 2018	SELL	$53.68 - $57.47 $640,187 - $685,387	-11,926 Reduced 6.67%	166,745 $9.52 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $153,455 - $171,272	3,193 Added 1.82%	178,671 $9.53 Million
Q2 2017 Aug 10, 2017	BUY	N/A	175,478	175,478 $8.53 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Account

Raymond James Trust N.A. Abbott Laboratories Transaction History